Dr. Shiwen Zhang 张世文
Chief Physician
Department of Head and Neck Surgical Oncology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of thyroid and parathyroid nodules. Comprehensive care for head and neck tumors, including laryngeal, hypopharyngeal, nasal, sinus, oral, parotid, and skin cancers. Specializes in tumor resection, functional reconstruction using flaps, endoscopic cosmetic thyroid surgery, and skull base procedures.
Dr. Zhang is Deputy Director of the First Department of Head and Neck Surgery at Yunnan Cancer Hospital. Holding a medical doctorate, Dr. Zhang completed postdoctoral training at the Kunming Institute of Zoology and served as a visiting scholar at MD Anderson Cancer Center and Nanyang Technological University. Recognized as a leading medical talent in Yunnan Province, Dr. Zhang specializes in radical resection and functional reconstruction for head and neck cancers.
Professional roles
- Chair, Head and Neck Oncology Professional Committee, Yunnan Anti-Cancer Association
- Vice Chair, Head and Neck Oncology Professional Committee, China Medical Education Association
- Member, Laryngeal Cancer Quality Control Expert Committee, National Cancer Center
- Standing Committee Member, Thyroid Cancer Professional Committee, Yunnan Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Shiwen). Papers usually list the name as Shiwen Zhang or Zhang S.
Selected publications
14 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- PeerJ, 2025 (senior author): Exosome and BCR-ABL mediated molecular alterations in endothelial cells in chronic myeloid leukemia: identification of seven genes and their regulatory network. PubMed 41424711
- Front Immunol, 2025 (senior author): Establishment of prognostic signature based on neutrophil extracellular traps-related genes in acute myeloid leukemia: a bioinformatics analysis. PubMed 41208992
- J Inflamm Res, 2025 (first author): CpG ODN Combined with Gold Nanorods Enhances Immune Activation and Its Potential Mechanism. PubMed 40922946
- Gland Surg, 2024 (first author): Comparison of thyroid surgery techniques: a retrospective cohort study and meta-analysis of traditional electric knife vs. straight bipolar electrocoagulation forceps. PubMed 39175701
- J Biomed Nanotechnol, 2022 (first author): Photothermolysis Mediated by Gold Nanorods Conjugated with Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Induces Apoptosis via the Mitochondrial Apoptosis Pathway in Laryngeal Squamous Cell Cancer. PubMed 35715914
- Bioengineered, 2022 (senior author): Optimization of endothelial growth factor receptor monoclonal antibody-gold nanorods photothermal therapy for laryngeal squamous cell carcinoma. PubMed 35067164
- J Cell Biochem, 2020 (senior author): microRNA-320a prevent Müller cells from hypoxia injury by targeting aquaporin-4. PubMed 32830348
- Int J Nanomedicine, 2014 (first author): Photothermolysis mediated by gold nanorods modified with EGFR monoclonal antibody induces Hep-2 cells apoptosis in vitro and in vivo. PubMed 24790435
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion